KBC Group NV Has $14.45 Million Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

KBC Group NV decreased its stake in Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 2.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 11,811 shares of the medical instruments supplier's stock after selling 242 shares during the period. KBC Group NV owned approximately 0.06% of Mettler-Toledo International worth $14,453,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. JPMorgan Chase & Co. increased its position in shares of Mettler-Toledo International by 14.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier's stock worth $332,634,000 after purchasing an additional 28,478 shares in the last quarter. Quest Partners LLC boosted its holdings in shares of Mettler-Toledo International by 878.1% in the 3rd quarter. Quest Partners LLC now owns 1,027 shares of the medical instruments supplier's stock worth $1,540,000 after acquiring an additional 922 shares in the last quarter. Allspring Global Investments Holdings LLC raised its position in Mettler-Toledo International by 14.0% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,240 shares of the medical instruments supplier's stock valued at $1,860,000 after purchasing an additional 152 shares during the last quarter. M&T Bank Corp boosted its stake in Mettler-Toledo International by 14.3% in the third quarter. M&T Bank Corp now owns 4,926 shares of the medical instruments supplier's stock worth $7,387,000 after purchasing an additional 615 shares in the last quarter. Finally, Nordea Investment Management AB grew its holdings in shares of Mettler-Toledo International by 29.8% during the fourth quarter. Nordea Investment Management AB now owns 105,823 shares of the medical instruments supplier's stock worth $129,919,000 after purchasing an additional 24,285 shares during the last quarter. Institutional investors own 95.07% of the company's stock.

Mettler-Toledo International Trading Up 2.2 %

Shares of MTD stock traded up $29.64 on Thursday, hitting $1,365.14. The stock had a trading volume of 77,144 shares, compared to its average volume of 113,077. Mettler-Toledo International Inc. has a twelve month low of $1,133.46 and a twelve month high of $1,546.93. The company has a fifty day moving average price of $1,260.70 and a two-hundred day moving average price of $1,343.47. The firm has a market cap of $28.80 billion, a P/E ratio of 36.79, a PEG ratio of 4.19 and a beta of 1.12.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The business had revenue of $954.54 million during the quarter, compared to analyst estimates of $941.93 million. On average, analysts expect that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current year.

Wall Street Analyst Weigh In

MTD has been the topic of several research reports. Stifel Nicolaus reduced their price target on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a "buy" rating on the stock in a research report on Monday, November 11th. Wells Fargo & Company decreased their price target on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an "equal weight" rating on the stock in a research note on Monday, November 11th. Citigroup raised Mettler-Toledo International from a "sell" rating to a "neutral" rating and upped their price objective for the stock from $1,200.00 to $1,300.00 in a report on Wednesday, December 11th. Wolfe Research started coverage on Mettler-Toledo International in a research report on Friday, December 13th. They set a "peer perform" rating for the company. Finally, Robert W. Baird reduced their target price on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a "neutral" rating on the stock in a research note on Monday, November 11th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $1,351.25.

Insider Buying and Selling

In related news, Director Elisha W. Finney sold 76 shares of the company's stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the sale, the director now owns 240 shares in the company, valued at approximately $314,820. This represents a 24.05 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Gerry Keller sold 140 shares of the firm's stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total value of $175,572.60. Following the completion of the transaction, the insider now owns 6 shares of the company's stock, valued at approximately $7,524.54. This represents a 95.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by company insiders.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.